The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
A Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?
Abstract
Heparin is a sulfated glycosaminoglycan isolated from animal organs that has been used clinically as an antithrombotic agent since the 1940s. In the early 1980s it was discovered that a unique pentasaccharide domain in some heparin chains activates antithrombin III (AT‐III), a serine protease inhibitor that blocks thrombin and factor Xa in the coagulation cascade. Sanofi‐Synthélabo and Organon developed a synthetic analogue of this pentasaccharide. The resulting antithrombotic drug arixtra, which went on the market in the USA and Europe in 2002, shows superior antithrombotic activity and brings about AT‐III‐mediated activity against factor Xa exclusively. Structure‐based design has subsequently led to analogues with longer‐lasting activity, such as idraparinux, as well as novel conjugates and long oligosaccharides with specific anti‐Xa and antithrombin activities. The new drug candidates are more selective in their mode of action than heparin and less likely to induce thrombocytopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cobalt(II)-Nitronyl Nitroxide Chains as Molecular Magnetic Nanowires
Caneschi, A., Gatteschi, D., Lalioti, N., Sangregorio, C., Sessoli, R., Venturi, G., Vindigni, A., Rettori, A., Pini, M. G., & Novak, M. A. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010504)40:9<1670::aid-anie16700>3.3.co;2-h · Cited by 1,154
The anticoagulant activation of antithrombin by heparin
Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N., & Carrell, R. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14683 · Cited by 685
Self-citationHeparin-induced Thrombocytopenia: Towards Consensus
Warkentin, T. E., Chong, B. H., & Greinacher, A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614206 · Cited by 542
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
Lindahl, U., Bäckström, G., Thunberg, L., & Leder, I. G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6551 · Cited by 498
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
van Boeckel, C. A. A., & Petitou, M. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199316713 · Cited by 382
Self-citationAnticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L., & Lindahl, U. (1984) · Biochemical Journal · doi:10.1042/bj2180725 · Cited by 342
Synthesis of thrombin-inhibiting heparin mimetics without side effects
Petitou, M., Hérault, J.-P., Bernat, A., Driguez, P.-A., Duchaussoy, P., Lormeau, J.-C., & Herbert, J.-M. (1999) · Nature · doi:10.1038/18877 · Cited by 326
Self-citationThe molecular-weight-dependence of the anti-coagulant activity of heparin
Laurent, T. C., Tengblad, A., Thunberg, L., Höök, M., & Lindahl, U. (1978) · Biochemical Journal · doi:10.1042/bj1750691 · Cited by 273
Danielsson, A., Raub, E., Lindahl, U., & Björk, I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66735-3 · Cited by 252
Petitou, M. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00078-6 · Cited by 241
Self-citationTotal synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III
Sinaÿ, P., Jacquinet, J.-C., Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., & Torri, G. (1984) · Carbohydrate Research · doi:10.1016/0008-6215(84)85236-2 · Cited by 237
Self-citationSTRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
Self-citationMechanism of Heparin Activation of Antithrombin
Desai, U. R., Petitou, M., Björk, I., & Olson, S. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7478 · Cited by 189
Self-citationMultiple functional domains of the heparin molecule.
Oosta, G. M., Gardner, W. T., Beeler, D. L., & Rosenberg, R. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.829 · Cited by 187
Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., Sînaÿ, P., Jacquinet, J., & Torri, G. (1986) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90633-5 · Cited by 152
Self-citationMode of interaction between platelet factor 4 and heparin
Maccarana, M., & Lindahl, U. (1993) · Glycobiology · doi:10.1093/glycob/3.3.271 · Cited by 138
Conformation of heparin pentasaccharide bound to antithrombin III
Hricovı́ni, M., Guerrini, M., Bisio, A., Torri, G., Petitou, M., & Casu, B. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590265 · Cited by 108
Self-citationFlyunt, R., Schuchmann, M. N., & von Sonntag, C. (2001) · Chemistry - A European Journal · doi:10.1002/1521-3765(20010216)7:4<858::aid-chem858>3.0.co;2-n · Cited by 99
Anti-Xa active heparin oligosaccharides
Choay, J., Lormeau, J. C., Petitou, M., Sînaÿ, P., Casu, B., Oreste, P., Torri, G., & Gatti, G. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90356-4 · Cited by 90
Self-citationPoletti, L., & Lay, L. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200200721 · Cited by 81
First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin
Petitou, M., Duchaussoy, P., Driguez, P., Jaurand, G., Hérault, J.-P., Jc, L., van Boeckel, C. A. A., & Herbert, J. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981116)37:21<3009::aid-anie3009>3.0.co;2-f · Cited by 64
Self-citationA unique trisaccharide sequence in heparin mediates the early step of antithrombin III activation
Petitou, M., Barzu, T., Hérault, J.-P., & Herbert, J. (1997) · Glycobiology · doi:10.1093/glycob/7.3.323-e · Cited by 34
Self-citationPetitou, M., Duchaussoy, P., Driguez, P., Jaurand, G., Hérault, J.-P., Jc, L., van Boeckel, C. A. A., & Herbert, J. (1998) · Angewandte Chemie · Cited by 9
Self-citation
Cited by
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Synthesis and medical applications of oligosaccharides
Seeberger, P. H., & Werz, D. B. (2007) · Nature · doi:10.1038/nature05819 · Cited by 755
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research
Boltje, T. J., Buskas, T., & Boons, G.-J. (2009) · Nature Chemistry · doi:10.1038/nchem.399 · Cited by 740
Glycomics: an integrated systems approach to structure-function relationships of glycans
Raman, R., Raguram, S., Venkataraman, G., Paulson, J. C., & Sasisekharan, R. (2005) · Nature Methods · doi:10.1038/nmeth807 · Cited by 439
Metadata
- Authors
- Petitou, M., & van Boeckel, C. A. A.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2004-06-09
- Volume
- 43
- Issue
- 24
- Pages
- 3118-3133
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2160715301
- Cited by
- 485
- References
- 24
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.